Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blind Controlled Proof-of-Concept Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions

NCT01701193 is registered in ClinicalTrials.gov with Temple Therapeutics BV as lead sponsor.

NCT NCT01701193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01701193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blind Controlled Proof-of-Concept Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions
Lead sponsor
Temple Therapeutics BV
Phase
Phase 1/2
Overall status
Completed
Start date
February 15, 2015
Completion date
October 20, 2016
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic adhesions